MRSN: Mersana Therapeutics Inc

7.32 USD 0.34 (4.44%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

MRSN exchange rate has changed by -4.44% for today. During the day, the instrument was traded at a low of 7.32 and at a high of 7.85.

Follow Mersana Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

MRSN News

13:55 Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet
15:55 Truist Securities slashes Mersana stock price target to $36 from $250
11:45 Guggenheim lowers Mersana stock price target to $30 from $125
17:49 Mersana stock price target raised to $17 from $6 at BTIG
15:44 Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
12:15 Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Lags Revenue Estimates
11:28 Mersana Therapeutics earnings missed by $4.71, revenue fell short of estimates
21:10 Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates
23:20 VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates
11:45 Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Beats Revenue Estimates
12:15 Amicus Therapeutics (FOLD) Misses Q2 Earnings Estimates
12:46 Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested - TipRanks.com
14:47 Mersana Therapeutics stock tumbles on 1-for-25 reverse split plan
13:42 Mersana Therapeutics to implement 1-for-25 reverse stock split Friday
12:49 Mersana Therapeutics to implement 1-for-25 reverse stock split
12:28 Mersana reports promising Phase 1 ADC trial results
19:01 Mersana Therapeutics at TD Cowen Summit: Strategic Updates on Oncology Innovations
12:12 Mersana Therapeutics to Present at Upcoming Investor Conferences
20:04 Truist raises Mersana stock target to $10, maintains Buy rating
13:32 CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
11:32 Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
11:22 Mersana Therapeutics earnings matched, revenue fell short of estimates
18:00 Walmart, Deere, Applied Materials set to report earnings Thursday

Daily Range

7.32 7.85

Year Range

0.26 8.19

Previous Close: 7.66
Open: 7.78

Bid: 7.32
Ask: 7.62

Low: 7.32
High: 7.85

Volume: 86

Daily Change: -4.44%
Month Change: 9.91%

6 Months Change: 1281.13%
Year Change: 372.26%

30 August, Saturday